The Society of Nuclear Medicine and Molecular Imaging has chosen its 2022 Image of the Year, and it’s one that is sure to interest anyone in the field of cardiac imaging.

“High-quality artificial intelligence-generated images preserve vital information from raw PET images without the additional radiation exposure from CT scans,” experts involved in the study explained.

The Detroit-based cancer institute achieved this landmark moment using the MRIdian A3i, which is the latest enhancement of the MRIdian system from ViewRay, Inc.

In a statement released on April 14, MITA cautioned that the coverage decision will “severely limit patient access” to amyloid PET diagnostics and anti-amyloid monoclonal antibodies treatment.

The Society for Nuclear Medicine & Molecular Imaging expressed "strong opposition" following CMS' decision, arguing there is no evidence to support limiting pay for such scans. 

In clinical trials, the therapy reduced patients' risk of death by 38%, along with significantly decreasing disease progression. 

Provider advocates praised the decision, calling it “one of the greatest success stories in nuclear medicine history.”

The Society of Nuclear Medicine and Molecular Imaging's program was established to ensure that institutions adhere to the strict regulatory training, qualification and performance standards necessary to safely deliver radiopharmaceutical therapies.